Calcium Phosphate Product Calculator

Calcium Phosphate Product Formula:

\[ Product = [Ca^{2+}] \times [PO_4^{3-}] \]

Calcium Phosphate Product:

Unit Converter ▲

Unit Converter ▼

From:	To:

1. What is Calcium Phosphate Product?

The Calcium Phosphate Product is a calculated value representing the product of serum calcium and phosphate concentrations. It is used to assess the risk of ectopic calcification and mineral bone disorders, particularly in patients with chronic kidney disease.

2. How Does the Calculator Work?

The calculator uses the simple formula:

\[ Product = [Ca^{2+}] \times [PO_4^{3-}] \]

Where:

\( [Ca^{2+}] \) — Serum calcium concentration (mmol/L)
\( [PO_4^{3-}] \) — Serum phosphate concentration (mmol/L)

Explanation: This product helps predict the risk of calcium-phosphate precipitation and soft tissue calcification.

3. Clinical Significance

Details: Elevated calcium-phosphate product (>4.4 mmol²/L² or >55 mg²/dL²) is associated with increased risk of vascular calcification, cardiovascular events, and mortality in CKD patients. Monitoring this parameter is crucial for managing mineral bone disease.

4. Using the Calculator

Tips: Enter serum calcium and phosphate concentrations in mmol/L. Both values must be positive numbers. The calculator will compute the product automatically.

5. Frequently Asked Questions (FAQ)

Q1: What is the normal range for calcium-phosphate product?
A: Generally, values below 4.4 mmol²/L² (55 mg²/dL²) are considered safe. Values above this threshold increase calcification risk.

Q2: Why is calcium-phosphate product important in CKD?
A: In CKD patients, impaired phosphate excretion leads to elevated levels, increasing the risk of vascular calcification and cardiovascular complications.

Q3: How often should calcium-phosphate product be monitored?
A: In CKD stages 3-5, it should be monitored every 1-3 months, depending on disease progression and treatment.

Q4: What interventions help lower elevated calcium-phosphate product?
A: Dietary phosphate restriction, phosphate binders, vitamin D analogs, and adequate dialysis in ESRD patients.

Q5: Are there limitations to using this calculation?
A: The product doesn't account for other factors like PTH levels, vitamin D status, or local tissue factors that influence calcification risk.